Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 25971330)

Published in Panminerva Med on September 01, 2015

Authors

D G Ribaldone1, S Fagoonee, M Astegiano, G Saracco, R Pellicano

Author Affiliations

1: Department of Gastroenterology and Hepatology, S. Giovanni Battista (Molinette) Hospital, Turin.

Articles by these authors

Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet (1990) 8.56

Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A (1992) 4.47

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology (1991) 4.47

Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41

Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A (1991) 2.05

Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication: a retrospective study. Panminerva Med (2010) 1.99

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut (2004) 1.65

Chronic Helicobacter pylori infection and migraine: a case-control study. Headache (2001) 1.54

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Hepatology (1998) 1.53

Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am J Gastroenterol (1999) 1.52

Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med (2000) 1.50

IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? Eur J Gastroenterol Hepatol (1997) 1.47

Helicobacter pylori and atherosclerosis: can current data be useful for clinical practice? Int J Cardiol (2008) 1.40

Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study. Panminerva Med (2008) 1.39

Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology (1987) 1.35

Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32

Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis (2010) 1.22

Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21

Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses (2000) 1.20

Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. Eur J Gastroenterol Hepatol (2000) 1.16

Sequence variation in hepatitis C viral isolates. J Hepatol (1991) 1.15

Helicobacter pylori infection and diabetes. Minerva Med (2010) 1.11

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology (1993) 1.11

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology (1995) 1.02

Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology (1995) 1.01

Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology (1991) 0.98

Covered metal stents for management of inoperable malignant colorectal strictures. Gastrointest Endosc (2000) 0.98

Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging (2004) 0.95

Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease. Curr Med Chem (2011) 0.93

Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology (1999) 0.92

Infectious agents and gastric tumours. An increasing role for Epstein-Barr virus. Panminerva Med (2003) 0.92

Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci (1999) 0.92

Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study. Panminerva Med (2002) 0.91

Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. Panminerva Med (2014) 0.89

The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species. Panminerva Med (2001) 0.88

Familial high-density lipoprotein deficiency (Tangier disease): the third Italian case. J Inherit Metab Dis (1988) 0.88

Natural history of perinatal hepatitis C virus infection. Clin Infect Dis (1996) 0.88

HCV genotypes in patients with liver disease of different stages and severity. J Hepatol (1997) 0.88

Lichen planus and hepatitis C virus infection: an updated critical review. Minerva Gastroenterol Dietol (2008) 0.88

[Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report]. Minerva Med (2007) 0.88

The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol (2000) 0.87

Laparoscopic cholecystectomy in cirrhotic patients. Dig Surg (2001) 0.87

Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy. J Viral Hepat (2000) 0.87

Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE data. J Biol Regul Homeost Agents (2008) 0.87

Seroprevalence of Helicobacter pylori infection among blood donors in Torino, Italy. Minerva Gastroenterol Dietol (2001) 0.87

Hepatitis C virus and human immunodeficiency virus: a dangerous dealing. Panminerva Med (2007) 0.86

Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view. Minerva Gastroenterol Dietol (2005) 0.86

Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker? Dig Liver Dis (2001) 0.86

GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia. Minerva Gastroenterol Dietol (2014) 0.86

Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis. Ital J Gastroenterol (1995) 0.86

Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum. Am J Gastroenterol (2001) 0.86

Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis? Minerva Med (2010) 0.86

A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies. Panminerva Med (2005) 0.85

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. Gut (2002) 0.85

Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. Minerva Gastroenterol Dietol (2007) 0.85

Association between Crohn's disease and Conn's syndrome. A report of two cases. Panminerva Med (2005) 0.85

Linear IgA disease and ulcerative colitis. Eur J Dermatol (1999) 0.85

2008 Clinical approach to irritable bowel syndrome. Minerva Gastroenterol Dietol (2008) 0.84

Carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography under general anesthesia. Minerva Med (2011) 0.84

Elevated serum chromogranin A in patients with hepatocellular carcinoma. Clin Exp Med (2002) 0.83

Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis. Aliment Pharmacol Ther (2001) 0.83

Hepatitis C virus infection and disease. Diagnostic problems. J Hepatol (1993) 0.83

Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Panminerva Med (2001) 0.83

US evaluation of patients affected by IBD: how to do it, methods and findings. Eur J Radiol (2009) 0.82

Antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci (1991) 0.82

Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication. Int Angiol (2009) 0.82

Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Aliment Pharmacol Ther (1998) 0.82

A new case of acromegaloid facial appearance (AFA) syndrome with an expanded phenotype. Clin Dysmorphol (2000) 0.82

Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations. J Med Virol (2002) 0.82

Epilepsy and celiac disease: review of literature. Panminerva Med (2011) 0.82

Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseases. New Microbiol (2003) 0.82

MicroRNAs in HBV-related hepatocellular carcinoma: functions and potential clinical applications. Panminerva Med (2015) 0.81

Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A,non-B viral hepatitis. A randomized controlled trial. Am J Clin Pathol (1992) 0.81

Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease. Aliment Pharmacol Ther (1997) 0.81

Gastric cancer as a stem-cell disease: data and hypotheses. Panminerva Med (2014) 0.80

Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid. Liver (1991) 0.80

Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease. Panminerva Med (2014) 0.80

Stem cells and Helicobacter-induced gastric cancer: where do we stand at the end of 2006. Panminerva Med (2006) 0.80

Adrenaline plus cyanoacrylate injection for treatment of bleeding peptic ulcers after failure of conventional endoscopic haemostasis. Dig Liver Dis (2002) 0.80

A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin. Aliment Pharmacol Ther (2006) 0.80

A 2008 panorama on osteoporosis and inflammatory bowel disease. Minerva Med (2008) 0.80